Cytokinetics
CYTK
CYTK
343 hedge funds and large institutions have $6.18B invested in Cytokinetics in 2024 Q4 according to their latest regulatory filings, with 48 funds opening new positions, 120 increasing their positions, 131 reducing their positions, and 47 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
8% less repeat investments, than reductions
Existing positions increased: 120 | Existing positions reduced: 131
3.67% less ownership
Funds ownership: 114.94% → 111.27% (-3.7%)
14% less capital invested
Capital invested by funds: $7.15B → $6.18B (-$965M)
Holders
343
Holding in Top 10
15
Calls
$182M
Puts
$103M
Top Buyers
| 1 | +$88M | |
| 2 | +$51.6M | |
| 3 | +$50M | |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$41.8M |
| 5 |
VPC
Vestal Point Capital
New York
|
+$40M |
Top Sellers
| 1 | -$217M | |
| 2 | -$92.8M | |
| 3 | -$61.1M | |
| 4 |
AC
Armistice Capital
New York
|
-$27.5M |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$25.4M |